Pharmaceuticals company Wockhardt announced H1FY25 & Q2FY25 results Q2FY25 Financial Highlights: QoQ growth of 7% in revenue in Q2FY25, Revenue for Q2FY25 of Rs 818 crore compared to Rs 762 crore in the Q2FY24. QoQ growth of 71% in EBITDA in Q2FY25, EBITDA for Q2FY25 of Rs 139 crore compared to Rs 81 crore in the Q2FY24. H1FY25 Financial Highlights: YoY growth of 10% in revenue in H1FY25, Revenue for H1FY25 of Rs 1,565 crore compared to Rs 1,420 crore in the H1FY24. YoY growth of 112% in EBITDA in H1FY25, EBITDA for H1FY25 of Rs 239 crore compared to Rs 113 crore in the H1FY24. Result PDF